Purple Biotech Ltd. (PPBT)

Purple Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	19.88	21.67	18.38	28	5.85
Depreciation & Amortization	0.2	0.2	0.23	0.24	0.18
Share-Based Compensation	1.88	2.41	2.08	2.65	1.27
Other Operating Activities	-41.88	-41.02	-35.95	-42.97	-12.88
Operating Cash Flow	-19.93	-16.74	-15.25	-12.09	-5.58
Capital Expenditures	-0	-0.23	-0.12	-0.16	-0.01
Acquisitions	-3.55	0	0	0.07	0
Change in Investments	16.68	19.82	13.16	-46.55	-0.59
Other Investing Activities	0.76	0.32	0.36	-2.96	0.15
Investing Cash Flow	13.88	19.91	13.41	-49.6	-0.45
Share Issuance / Repurchase	6.56	1.5	1.76	74.05	6.04
Debt Issued / Paid	-0.17	-0.17	-0.15	-0.18	-0.17
Other Financing Activities	-0.95	-0.22	-0.1	-5.38	-0.64
Financing Cash Flow	5.45	1.11	1.51	68.49	5.23
Exchange Rate Effect	0.05	-0.15	-0.02	0.06	0.02
Net Cash Flow	-0.6	4.29	-0.33	6.8	-0.8
Free Cash Flow	-19.93	-16.96	-15.37	-12.25	-5.59
Free Cash Flow Per Share	-1.00	-0.95	-8.75	-10.65	-28.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).